Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T19:11:16.140Z Has data issue: false hasContentIssue false
  • English
  • Français

Once versus Thrice Daily Thiothixene in the Treatment of Schizophrenic In-Patients

Published online by Cambridge University Press:  29 January 2018

J. Hillary Lee ,
Marc Branchey ,
E. Janet Haher ,
Ervin Varga  and
George M. Simpson
J. Hillary Lee
Affiliation:
Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
Marc Branchey
Affiliation:
Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
E. Janet Haher
Affiliation:
Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
Ervin Varga
Affiliation:
Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
George M. Simpson
Affiliation:
Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
Get access Rights & Permissions [Opens in a new window]

Extract

Reports have been accumulating in the literature attesting to the failure of patients, particularly out-patients, to take medication as prescribed (Stewart and Cluff, 1972; Moulding et al., 1970). The incidence of these failures, which may include anything from missing occasional doses to taking no medication at all, has been reported to range from 25–59 Per cent. In addition, it has not been possible to identify those patients who will have the highest failure rates (Blackwell, 1972). While most of the studies have involved medical patients, it is probably legitimate to assume that schizophrenic patients are at least as unreliable in taking medication as the medical patients. Thus, in one study of 125 psychiatric patients, Willcox et al. (1965) found that 48 per cent took no medication at all.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 125 , Issue 584 , July 1974 , pp. 73 - 78
Copyright
Copyright © Royal College of Psychiatrists, 1974 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Blackwell, B. (1972) The drug defaulter. Clinical Pharmacology and Therapeutics, 13, 841–8.CrossRefGoogle ScholarPubMed
Bergner, P.-E., Berniker, K., Cooper, T. B., Gradijan, J. R. & Simpson, G. M. (1974) Lithium kinetics in man: effect of variation in dosage patterns. British Journal of Pharmacology. In press.CrossRefGoogle Scholar
Brophy, J. J. (1969) Single daily dose of neuroleptic drugs. Diseases of the Nervous System, 30, 120–23.Google Scholar
Chien, C. & DiMascio, A. (1971) Clinical effects of various schedules of medication. Behavioral Neuropsychiatry, 3, 5–9.Google ScholarPubMed
Denber, H. C. B. & Travis, J. (1958) Chlorpromazine in the treatment of mental illness, V: Administrative problems. Psychiatric Quarterly, 32, 538–45.CrossRefGoogle ScholarPubMed
Haden, P. (1959) Drug-single and multiple daily dosage American Journal of Psychiatry, 115, 932–3.CrossRefGoogle Scholar
Honigfeld, G. & Klett, C. J. (1965) The Nurses’ Observation Scale for Inpatient Evaluation (NOSIE). Journal of Clinical Psychology, 21, 65–9.3.0.CO;2-I>CrossRefGoogle Scholar
Hruska, M., Bruck, M. & Hsu, J. J. (1966) Therapeutic effects of different modes of chlorpromazine administration. Diseases of the Nervous System, 27, 522–7.Google Scholar
Leff, J. P. & Wing, J. K. (1971) ‘Trial of maintenance therapy in schizophrenia. British Medical Journal, iii, 599–604.CrossRefGoogle Scholar
Moulding, T., Onstad, G. D. & Sbarbaro, J. A. (1970) Supervision of outpatient drug therapy with the medication monitor. Annals of Internal Medicine, 73, 559–64.CrossRefGoogle ScholarPubMed
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale (BPRS). Psychological Reports, 10, 799–802.CrossRefGoogle Scholar
Peterson, D. B. & Olsen, G. W. (1963) Single vs. multiple dose administration of tranquilizing medication. Psychiatric Studies + Projects, No. 14. Washington, D.C., Mental Health Service of the American Psychiatric Association, 2–4.Google Scholar
Polvan, N., Akpinar, S., Ahmed, M. B. & Itil, T. M. (1971) Different effects of trifluoperazine when administered daytime or night. British Journal of Psychiatry, 119, 601–2.CrossRefGoogle ScholarPubMed
Roberts, F. J. (1961) Single daily dose treatment of psychiatric patients with phenothiazine derivatives. Journal of Mental Science, 107, 104–8.CrossRefGoogle ScholarPubMed
Simpson, G. M. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, Suppl. 212, 11–19.CrossRefGoogle Scholar
Simpson, G. M. Beckles, D., Islalski, Z. & Lee, J. H. (1972) Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of EX 10-029, a new morphanthridine derivative. Journal of Clinical Pharmacology, 12, 142–53.Google Scholar
Stewart, R. B. & Cluff, L. E. (1972) A review of medication errors and compliance in ambulant patients. Clinical Pharmacology and Therapeutics, 13, 463–8.CrossRefGoogle ScholarPubMed
Tibbets, J. C. N. (1958a) Single daily dose of chlorpromazine. Lancet, i, 689.CrossRefGoogle Scholar
Tibbets, J. C. N. (1958b) Single daily dose of chlorpromazine. Lancet, ii, 590.CrossRefGoogle Scholar
Vestre, N. D. & Schiele, B. C. (1966) An evaluation of slow-release and regular thioridazine and two medication schedules. Current Therapeutic Research, 8, 585–91.Google ScholarPubMed
Willcox, D. R. C., Gillan, R. & Hare, E. H. (1965) Do psychiatric out-patients take their drugs? British Medical Journal, ii, 790–92.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.